Published: Feb 19, 2021 2:30 PM

** Thanks for downloading this episode. If you'd like to stay in touch with our continuing story, Season 2 continues at This Medical Life, in which Dr Travis Brown continues his exploration of diseases and our approaches to treatment from history to the modern day. Have a look in your podcast app now for This Medical Life, and hit subscribe so you never miss an episode **

In 1952, George Papanicolaou with the National Cancer Institute embarked on the first ever cervical screening trial. The results were remarkable and the first demonstration of the power of screening an asymptomatic population.

However, the path to this point took decades of perseverance and self-belief. This feat changed the course of medicine and can be attributed to two people: George and Mary Papanicolaou.

Cervical screening is one of the most effective screening programs ever initiated.

Combined with the recent advancements of HPV molecular testing and the HPV vaccine, Cervical cancer is now relatively uncommon and has an excellent prognosis.



SPECIAL GUEST

Dr Cos Fusco
Doctor of Health Science, Master of Medical Science (Pathology)
Fellow of the International Academy of Cytology
CT(ASC) Australian Society of Cytology

Currently Supervising Cytologist Clinpath Pathology

Additionally, Dr Fusco is a current committee member of the RCPAQAP Cytopathology advisory committee 2019-2023 and Scientific coordinator (SA) for The IMPACT National HPV study.

He started his cytology training in 1986 at the then Gribbles Pathology. He worked in Cytology and Histology at Gribbles, IMVS, Clinpath and Adelaide Pathology Partners. In 2006, Dr Fusco started the Cytology laboratory at Adelaide Pathology Partners at the invitation of Dr Fergus Whitehead, and continued with this role post merger with Clinpath Pathology.

His Doctoral Thesis was based on HPV HR DNA testing, HPV vaccination and molecular biomarkers and the potential impacts, on the Australian cervical screening program. Cervical cancer and HPV related cancers are an interest and a focus for research. He has a strong interest and involvement in Endobronchial Ultrasound FNA (EBUS FNA) collection for lung cancer staging and diagnosis.





Contents


Andromachi Papanikolaou - Wikipedia

Published: Feb 19, 2021 2:30 PM
** Thanks for downloading this episode. If you'd like to stay in touch with our continuing story, Season 2 continues at <a href="https://thismedicallife.com.au/">This Medical Life</a>, in which Dr Travis Brown continues his exploration of diseases and our approaches to treatment from history to the modern day. Have a look in your podcast app now for This Medical Life, and hit subscribe so you never miss an episode **
In 1952, George Papanicolaou with the National Cancer Institute embarked on the first ever cervical screening trial. The results were remarkable and the first demonstration of the power of screening an asymptomatic population.
However, the path to this point took decades of perseverance and self-belief. This feat changed the course of medicine and can be attributed to two people: George and Mary Papanicolaou.
Cervical screening is one of the most effective screening programs ever initiated.
Combined with the recent advancements of HPV molecular testing and the HPV vaccine, Cervical cancer is now relatively uncommon and has an excellent prognosis.
 
SPECIAL GUEST
Dr Cos Fusco Doctor of Health Science, Master of Medical Science (Pathology) Fellow of the International Academy of Cytology CT(ASC) Australian Society of Cytology
Currently Supervising Cytologist Clinpath Pathology
Additionally, Dr Fusco is a current committee member of the RCPAQAP Cytopathology advisory committee 2019-2023 and Scientific coordinator (SA) for The IMPACT National HPV study.
He started his cytology training in 1986 at the then Gribbles Pathology. He worked in Cytology and Histology at Gribbles, IMVS, Clinpath and Adelaide Pathology Partners. In 2006, Dr Fusco started the Cytology laboratory at Adelaide Pathology Partners at the invitation of Dr Fergus Whitehead, and continued with this role post merger with Clinpath Pathology.
His Doctoral Thesis was based on HPV HR DNA testing, HPV vaccination and molecular biomarkers and the potential impacts, on the Australian cervical screening program. Cervical cancer and HPV related cancers are an interest and a focus for research. He has a strong interest and involvement in Endobronchial Ultrasound FNA (EBUS FNA) collection for lung cancer staging and diagnosis.
 
Contents
 <a href="http://en.wikipedia.org/wiki/Andromachi_Papanikolaou">Andromachi Papanikolaou</a> - Wikipedia

Welcome to the This Medical Life podcast. Our mission is to share stories about the triumphs and tragedies of diseases and illnesses from ancient times up until what we know today. It is about those scientific and medical minds who came before us and how, every single day, we stand on the shoulders of giants. This is a podcast about the stories of medicine.


Hosted by Dr. Travis Brown and Steve Davis, our target audience is General Practitioners, medical students, and other health professionals. We hope to educate, inspire and celebrate those who choose to care for others in their profession. From experience, we know that our audience extends beyond these fields and would like to welcome anyone to listen. The stories of those who came before us are nothing short of remarkable and we hope you enjoy them as much as we do.

Production by Tim Whiffen

Design by Tom Buzz

Advertisement